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Abstract
Efforts to achieve effective and meaningful patient and public involvement (PPI) in healthcare have existed for 
nearly a century, albeit with limited success. This brief commentary discusses a recent paper by Carter and Martin 
exploring the “Challenges Facing Healthwatch, a New Consumer Champion in England,” and places these challenges 
in the context of the broader struggle to give a voice to healthcare consumers and citizens. With an overview of what 
can go right and—perhaps more importantly—what can go wrong, the question remains: will Healthwatch—and 
other PPI efforts in healthcare—represent the voice of consumers or citizens and will it matter?
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From the regional health authorities of Canada to the district health boards of New Zealand and the foundation trusts of England to the health systems 
agencies of the United States, examples of democratic 
governments attempting to implement meaningful patient and 
public involvement (PPI) in healthcare abound.1-7 However, 
identifying successful efforts is more challenging, owing to the 
lack of a clear definition of PPI and conflicting rationales for 
its existence.8 While patients have occasionally proven able to 
contribute to healthcare planning and development,9 failures 
to implement effective consumer governance in healthcare 
can be found in Canada,1 the United Kingdom,3 and the 
United States.2,4-6,10 Yet the dream of achieving effective and 
meaningful PPI in healthcare—elusive as it seems to be—is 
still alive and well.11 These efforts have taken on yet another 
form in England, as Carter and Martin write in “Challenges 
Facing Healthwatch, a New Consumer Champion in England.”12
Formally established by the Health & Social Care Act 2012, 
Healthwatch proclaims its mission to be “the consumer 
champion for health and social care.” Healthwatch consists 
of both local bodies (Local Healthwatch) and a national 
body (Healthwatch England). The Local Healthwatch are 
given “a seat on the statutory health and well-being boards…
[enabling] people to share their views and concerns about 
their local health and social care services…[alerting] 
Healthwatch England…to concerns about specific care 
providers, health or social care matters, [and providing] 
people with information about their choices and what to do 
when things go wrong…[including] information about local 
health and care services and how to access them.”13 Given 
England’s history of a string of PPI efforts over the last 40 
years including Community Health Councils, PPI Forums, 
and Local Involvement Networks (LINks),12 the most pressing 
question may not be “Will Healthwatch succeed where others 
have failed?” but rather “Will Healthwatch represent the voice 
of healthcare consumers or citizens?” and most importantly, 
“Will it matter?”
PPI in healthcare hinges on the idea of representation, a 
concept which Pitkin delineated to include formal, descriptive, 
and substantive dimensions, which refer respectively to how 
representatives are chosen, the extent to which representatives 
resemble constituents, and the extent to which representatives 
accurately seek the interests of constituents.14 More plainly, 
successful PPI must be intentional about who is to participate, 
how they are selected, what role they are to play, and what 
ends they are to pursue.15 All too often, these questions are 
not thoroughly answered, and this appears to be the case with 
Healthwatch.
Although Healthwatch has formal authority by virtue of the 
fact that they are granted a seat on local health and well-being 
boards, the mechanism of formal representation is less clear. 
Typically, representatives are authorized and held accountable 
by those they represent through mechanisms of formal 
representation such as elections. However, Healthwatch 
jurisdictions are not necessarily defined according to 
traditional geopolitical boundaries (eg, counties). The end 
result is that the local community may be ill defined and 
represented by a variety of decision-makers and stakeholders 
at different levels, which may overlap to differing degrees, 
making it much more difficult for local citizens and/or 
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consumers to have an effective voice.12
Moreover, it seems that the local people involved in 
Healthwatch are volunteers. Reliance on a voluntary model 
is concerning, as prior PPI failures can be traced in part to 
challenges getting an adequate number of consumers to 
participate.16 Furthermore, despite statutory requirements 
that local Healthwatch must be “inclusive and reflect the 
diversity of the community it serves,”13 costs inherent in 
participation are likely to pose a barrier to those who may 
be lower income or otherwise disadvantaged. Consequently, 
these individuals may find that their voice is excluded from 
the discussion altogether. Even in the midst of inclusion, 
exclusion can be prevalent. As status generalization theory 
suggests, small groups recreate the power dynamics found in 
society at large, which tends to amplify the voices of those 
with higher social standing and drown out the voices of the 
meek.17-19 Thus, efforts at exclusion may be just as important as 
efforts at inclusion. Political scientist, Suzanne Dovi, stresses 
that “Not only do some voices need to be brought in, some 
voices need to be muted.”20 Notably, there is evidence that 
further formalizing representation through the introduction 
of elections is unlikely to remedy the limitations inherent in 
this voluntary model of PPI.7,21
Next, there is the question of why certain individuals are 
selected for participation. For example, service users may 
conceivably participate as individual consumers of services, 
as advocates for a group of consumers, or as citizens 
representing the community.22 As Carter and Martin suggest, 
there are conflicting messages as to whether Healthwatch is 
to be a “consumer champion” or a mechanism to “strengthen 
the collective voice of local people.”12 Further complicating 
matters, consumers are not a homogeneous group and certain 
types of consumers are more likely to engage in PPI activities 
than others.23
There is also an inherent paradox between the intention 
and the implementation of PPI manifested in seeking the 
involvement of ‘ordinary’ patients, consumer advocates, or 
public citizens who possess the extraordinary ability to be 
effective representatives.24 John Gaventa reminds us that 
“mandates for participation from ‘above’ must be linked with 
pre-existing capacities for participation from ‘below’”25 and 
many have argued that lay persons simply lack the requisite 
skills to be effective participants in governance and other 
decision-making settings.26-29 Consequently, there is an 
ongoing debate about whether such ‘ordinary’ individuals 
can play a meaningful role in healthcare governance and 
decision-making without first being co-opted by established 
interests.30,31 
Finally, there is the question of what ultimate influence we 
expect participants to have on measurable outcomes. The law 
stipulates that local Healthwatch are tasked with obtaining the 
“views of local people regarding health and care services” and 
relaying that information to decision-makers.12 However, this 
is left open to interpretation. As Carter and Martin discuss, 
this could be consistent with promoting voice among the 
local citizenry or promoting choice among consumers.12 
There is likely to be variation in interpretation across local 
Healthwatch, which poses a challenge. Without knowing 
expressly what Healthwatch is intended to do, it becomes 
difficult to know whether it is achieving the intended outcome. 
As Carter and Martin summarize it: “If action does not result, 
apparent avenues for voice might turn out to be culs-de-sac or 
a ‘dialogue of the deaf.’”12
David Brindle writes in The Guardian that the Staffordshire 
hospitals scandal “reminds us of the critical importance of 
PPI in the care system – and of what can happen when the 
voices of patients and family carers are not heard.”32 Indeed, 
Healthwatch makes clear that in all of the recent scandals 
(eg, Mid-Staffordshire, Morecambe Bay, and Winterbourne 
View), “local people were raising concerns and worries 
long before they were properly listened to.”33 Clearly there 
is an ongoing desire to give patients and citizens a voice in 
healthcare governance, but merely replacing one program 
with another when dissatisfaction reaches a tipping point is 
unlikely to bring England—or any other nation—closer to 
realizing that desire. 
To be certain, Healthwatch—like other PPI efforts—faces 
a host of challenges, including a struggle to demonstrate 
legitimacy, limited financial resources, conflicts of interest 
vis-à-vis the established interests of the healthcare system, 
and the risk of being co-opted by those very same interests.12 
However, until policy-makers intentionally design PPI efforts 
that are clear about who participates, how they are selected, 
why they have been selected (ie, as consumers or citizens), 
what activities are within their purview, and how they will be 
held accountable by those they are intended to represent, it is 
doubtful that the voice of consumers or citizens will ever be 
brought to bear upon healthcare in a truly meaningful way.
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